Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

ASH 2012 Report – Potential gene therapy approach to sickle cell disease highlighted at ASH

Written by | 21 Dec 2012

Proof-of-concept animal study selected as one of the best presentations at 54th American Society of Hematology Annual Meeting and Exposition.

PRT versus IMRT toxicity in prostate cancer

Written by | 21 Dec 2012

There is no difference between proton radiotherapy (PRT) and intensity-modulated radiotherapy (IMRT) when comparing the toxicity among  patients with prostate cancer at 12 months post-treatment according to a… read more.

ASCO 2012 Report – Crizotinib shows promise in patients with advanced NSCLC with ROS1 rearrangements

Written by | 20 Nov 2012

by Marybeth Burke – Crizotinib demonstrated significant anti-tumour activity in patients with advanced non-small cell lung cancer (NSCLC) harbouring ROS1 rearrangements,

ASCO 2012 Report – Investigational drug shows promise in advanced melanoma, kidney cancer, and NSCLC

Written by | 20 Nov 2012

by Marybeth Burke – The investigational drug BMS-936558 caused tumour shrinkage in up to a quarter of patients with advanced melanoma, kidney and NSCLC cancers,

ASCO 2012 Report – Afatinib delays tumour progression in advanced NSCLC

Written by | 20 Nov 2012

by Marybeth Burke – Afatinib, an irreversible ErbB-family blocker, delays progression of advanced lung cancer in patients with epidermal growth factor receptor (EGFR) mutations compared with standard chemotherapy,

‘Fitness and fatness’: Not all obese people have the same prognosis

Written by | 31 Oct 2012

Second study sheds light on the ‘obesity paradox’ People can be obese but metabolically healthy and fit, with no greater risk of developing or dying from cardiovascular disease… read more.

'Fitness and fatness': Not all obese people have the same prognosis

Written by | 31 Oct 2012

Second study sheds light on the ‘obesity paradox’ People can be obese but metabolically healthy and fit, with no greater risk of developing or dying from cardiovascular disease… read more.

ITS 2012 Report – Difficult donor issues in the time of donor shortages

Written by | 5 Oct 2012

by Maria Dalby – Introduction – In many ways waiting lists to receive an organ transplantation look very much the same today as they did a decade ago… read more.

ESMO 2012 Report – Urgent need for integrated oncology and palliative care

Written by | 28 Sep 2012

The European Society for Medical Oncology (ESMO) has awarded ESMO Designated Center of Integrated Oncology and Palliative Care accreditation to 16 new oncology centres.

Nanochains mark micrometastases for early diagnosis, treatment

Written by | 28 Sep 2012

Malignant cells that leave a primary tumor, travel the bloodstream and grow out of control in new locations cause the vast majority of cancer deaths.

ERS 2012 Report – Sleep apnoea linked with increased risk of cancer death

Written by | 28 Sep 2012

Sleep apnoea severity has been associated with increased cancer mortality in a new study.

ESC 2012 Report – Metabolically healthy, fit obese persons appear to have normal CVD and cancer risks

Written by | 17 Sep 2012

by Bruce Sylvester – Obese persons who are metabolically healthy and fit have no more risk of developing or dying from cardiovascular disease or cancer than persons of… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.